Examination of the mechanism by which heparin antagonizes activation of a model endothelium by interferon-gamma (IPN-γ)

Clinical and Experimental Immunology

Volumn 107, Issue 3, 1997, Pages 578-584

  Douglas, M S ^a   Rix, D A ^a   Dark, J H ^a   Talbot, D ^a   Kirby, J A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Class II MHC antigen; Endothelial cell; Glycosaminoglycan; Heparin; Interferon gamma

Indexed keywords

CHONDROITIN SULFATE; GAMMA INTERFERON; GLYCOSAMINOGLYCAN; HEPARIN; HEPARIN LYASE; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ARTICLE; BIOSYNTHESIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

EID: 0031054407     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.3141206.x     Document Type: Article

References (39)

1. Farrar MA, Schrieber RD. The molecular cell biology of interferon-γ and its receptor. Ann Rev Immunol 1993; 11:571-611.
2. + allogeneic vascular endothelium. Transplantation 1993; 56:128-34.
3. Pober JS, Gimbrone MA, Lapierre LA, Mendrick DL, Fiers W, Rothlein R, Springer TA. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol 1986; 137:1893-6.
4. Brown Z, Gerritsen ME, Carley WW, Strieter RM, Kunkel SL, Westwick J. Chemokine gene expression and secretion by cytokine-activated human microvascular endothelial cells. Am J Pathol 1994; 145:913-21.
5. Klein NJ, Shennan GI, Heyderman RS, Levin M. Alteration in glycosaminoglycan metabolism and surface charge on human umbilical vein endothelial cells induced by cytokines, endotoxin and neutrophils. J Cell Science 1992; 102:821-32.
6. Ihrcke NS, Wrenshall LE, Lindman BJ, Platt JL. Role of heparan sulfate in immune system-blood vessel interactions. Immunol Today 1993; 14:500-5.
7. Paulsson M, Yurchenco PD, Ruben GC, Engel J, Timpl R. Structure of low density heparan sulphate proteoglycan isolated from a mouse tumor basement membrane. J Mol Biol 1987; 197:297-313.
8. Gallagher JT, Walker A. Molecular distinctions between heparan sulphate and heparin. Biochem J 1985; 230:665-74.
9. Lindahl U, Lidholt K, Spillmann D, Kjellen L. More to 'heparin' than anticoagulation. Thromb Res 1994; 75:1-32.
10. Witt DP, Lander AD. Differential binding of chemokines to glycosaminoglycan subpopulations. Curr Biology 1994; 4:394-400.
11. Rider CC. Many cytokines and interleukins bind to glycosaminoglycans. Immunol Today 1993; 14:615.
12. Lantz M, Thysell H, Nilsson E, Olsson I. On the binding of tumour necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin. J Clin Invest 1991; 88:2026-31.
13. Lortat-Jacob H, Grimaud JA. Binding of interferon-gamma to heparan sulfate is restricted to the heparin-like domains and involves carboxylic - but not N-sulfated - groups. Biochim et Biophys Acta 1992; 1117:126-30.
14. Vlodavsky I, Bar-Shavit R, Ishai-Michaeli R, Bashkin P, Fuks Z. Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism? Trends Biochem Sci 1991; 16:268-71.
15. Erikkson AE, Cousins LS, Matthews BW. Refinement of the structure of human fibroblast growth factor at 1·6Å resolution and analysis of presumed heparin binding sites by selenate substitution. Protein Sci 1993; 2:1274-84.
16. Cardin AD, Weintraub HJ. Molecular modelling of protein-glycosaminoglycan interactions. Arteriosclerosis 1989; 9:21-32.
17. Spillmann D, Lindahl U. Glycosaminoglycan-protein interactions: a question of specificity. Curr Opin Struct Biol 1994; 4:677-82.
18. + T lymphocytes to intact or heparinase treated subendothelial matrix by diffusible or anchored RANTES or MIP-1β. J Immunol 1994; 153:4899-906.
19. Korlipara LVP, Pleass HCC, Taylor RMR, Forsythe JLR, Proud G, Kirby JA. Cultured endothelium: heparin antagonises the induction of Class II molecules by interferon-γ. Transplantation 1994; 58: 1426-9.
20. Rix DA, Douglas MS, Talbot D, Dark JH, Kirby JA. Role of glycosaminoglycans in regulation of the immunogenicity of human vascular endothelial cells. Clin Exp Immunol 1996; 104:60-65.
21. Daubener W, Nockemann S, Gutsche M, Hadding U. Heparin inhibits the antiparasitic and immune modulatory effects of human recombinant interferon-γ. Eur J Immunol 1995; 25:688-92.
22. Linhardt RJ, Cooney CL, Galliher PM. Polysaccharide lyases. Appl Biochem Biotechnol 1986; 12:135-77.
23. Edgell CS, McDonald CC, Graham JB. Permanent cell line expressing human factor VIII-related antigen established by hybridisation. Proc Natl Acad Science USA 1983; 80:3734-7.
24. Edgell C-JS, Haizlip JE, Bagnell CR, Packenham JP, Harrison P, Wilbourn B, Madden VJ. Endothelium specific Weibel-Palade bodies in a continuous human cell line EA.hy926. In Vitro Cell Dev Biol 1990; 26:1167-72.
25. Brown KA, Vora A, Biggerstaff J et al. Application of an immortalised human endothelial cell line to the leukocyte: endothelial adherence assay. J Immunol Methods 1993; 163:13-22.
26. + T cells to endothelial cells in the absence of contaminating accessory cells. Transplantation 1994; 57:1628-37.
27. Bender JR, Sadeghi MM, Watson C, Pfau S, Pardi R. Heterogeneous activation thresholds to cytokines in genetically distinct endothelial cells: evidence for diverse transcriptional responses. Proc Natl Acad Science USA 1994; 91:3994-8.
28. Thornton SC, Mueller SN, Levine EM. Human endothelial cells: use of heparin in cloning and long-term serial cultivation. Science 1983; 222:623-5.
29. Keller KM, Brauer PR, Keller JM. Modulation of cell surface heparan sulfate structure by growth of cells in the presence of chlorate. Biochemistry 1989; 28:8100-7.
30. Hashimoto Y, Orellana A, Gil G, Hirschberg CB. Molecular cloning and expression of rat liver N-heparan sulfate sulfotransferase. J Biol Chem 1992; 267:15744-50.
31. Greve H, Cully Z, Blumberg P, Kresse H. Influence of chlorate on proteoglycan biosynthesis by cultured human fibroblasts. J Biol Chem 1988; 263:12886-92.
32. Lortat-Jacob H, Turnbull JE, Grimaud JA. Molecular organization of the interferon-γ binding domain in heparan sulphate. Biochem J 1995; 310:497-505.
33. Roghani M, Moscatelli D. Basic fibroblast growth factor is internalised through both receptor-mediated and heparan sulphate-mediated mechanisms. J Biol Chem 1992; 267:22156-62.
34. Lortat-Jacob H, Kleinman HK, Grimaud JA. High-affinity binding of interferon-γ to a basement membrane complex (Matrigel). J Clin Invest 1991; 87:878-83.
35. Camejo EH, Rosengren B, Camejo G, Sartipy P, Fager G, Bondjers G. Interferon gamma binds to extracellular matrix chondroitin sulphate proteoglycans, thus enhancing its cellular response. Arterioscler Thromb Vasc Biol 1995; 15:1456-65.
36. Lortat-Jacob H, Grimaud JA. Interferon-γ binds to heparan sulphate by a cluster of amino acids located in the C-terminal part of the molecule. FEBS Letters 1991; 280:152-4.
37. Gray PW, Leung DW, Pennica D et al. Expression of human immune interferon cDNA in E. coli and monkey cells. Nature 1982; 295:503-8.
38. Szente BE, Soos JM, Johnson HM. The C-terminus of IFN-γ is sufficient for intracellular function. Biochem Biophys Res Commun 1994; 203:1645-54.
39. Leinikki PO, Calderon J, Luquette MH, Schrieber RD. Reduced receptor binding by a human interferon-γ fragment lacking 11 carboxyl-terminal amino acids. J Immunol 1987; 139:3360-6.